| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $104,440 | 1 | 17 |
Sells | $522,380 | 5 | 83 |
| Chernett Jorey | 10 percent owner | 1 | $104,440 | 0 | $0 | $104,440 |
| Black Jeffrey G. | Chief Financial Officer | 0 | $0 | 2 | $154,500 | $-154,500 |
| ABALLI JOHN | President and CEO | 0 | $0 | 3 | $367,880 | $-367,880 |
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its flagship product, AVISE CTD, aids in distinguishing between various connective tissue …
Over the last 12 months, insiders at Exagen Inc. have bought $104,440 and sold $522,380 worth of Exagen Inc. stock.
On average, over the past 5 years, insiders at Exagen Inc. have bought $139,619 and sold $762,428 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chernett Jorey (10 percent owner) — $104,440.
The last purchase of 14,000 shares for transaction amount of $104,440 was made by Chernett Jorey (10 percent owner) on 2026‑10‑19.
| 2026-10-19 | Chernett Jorey | 10 percent owner | 14,000 0.058% | $7.46 | $104,440 | +6.06% | ||
| 2026-10-16 | Sale | ABALLI JOHN | President and CEO | 34,294 0.1443% | $7.87 | $269,791 | +1.42% | |
| 2026-09-01 | Sale | Black Jeffrey G. | Chief Financial Officer | 20,614 0.0865% | $7.22 | $148,782 | +14.75% | |
| 2026-03-03 | Sale | ABALLI JOHN | President and CEO | 15,698 0.0706% | $3.62 | $56,827 | +34.69% | |
| 2026-02-24 | Sale | ABALLI JOHN | President and CEO | 11,430 0.0493% | $3.61 | $41,262 | +23.85% | |
| 2026-02-24 | Sale | Black Jeffrey G. | Chief Financial Officer | 1,584 0.0068% | $3.61 | $5,718 | +23.85% | |
| 2025-10-16 | Sale | ABALLI JOHN | President and CEO | 31,787 0.145% | $11.82 | $375,598 | -59.30% | |
| 2025-09-02 | Sale | Black Jeffrey G. | Chief Financial Officer | 20,466 0.0948% | $9.79 | $200,362 | -50.10% | |
| 2025-03-25 | Sale | NMSIC Co-Investment Fund, L.P. | 10 percent owner | 350,000 1.6718% | $3.30 | $1.16M | +81.09% | |
| 2024-11-20 | Sale | NMSIC Co-Investment Fund, L.P. | 10 percent owner | 200,000 0.9498% | $3.30 | $660,040 | +61.31% | |
| 2024-11-15 | Black Jeffrey G. | Chief Financial Officer | 22,298 0.13% | $2.98 | $66,448 | +121.48% | ||
| 2024-11-14 | ABALLI JOHN | President and CEO | 24,305 0.1336% | $2.81 | $68,297 | +124.48% | ||
| 2024-05-16 | ABALLI JOHN | President and CEO | 40,401 0.2429% | $1.92 | $77,570 | +64.55% | ||
| 2024-03-04 | Sale | Adawi Kamal | CFO and Corporate Secretary | 12,784 0.0732% | $1.91 | $24,407 | +44.47% | |
| 2024-02-06 | Sale | Adawi Kamal | CFO and Corporate Secretary | 6,738 0.0337% | $1.95 | $13,133 | +20.90% | |
| 2023-10-17 | Sale | ABALLI JOHN | President and CEO | 33,819 0.1967% | $1.75 | $59,018 | +14.88% | |
| 2023-06-15 | TULLIS JAMES L L | 10 percent owner | 167 0.0009% | $3.11 | $519 | -39.13% | ||
| 2023-03-02 | Sale | Hazeltine Mark | Chief Business Officer | 3,667 – | $0 | $0 | +0.42% | |
| 2023-03-02 | Sale | Adawi Kamal | CFO and Corporate Secretary | 3,667 0.0209% | $2.30 | $8,432 | +0.42% | |
| 2023-02-08 | Sale | Hazeltine Mark | Chief Business Officer | 5,821 0.0336% | $2.69 | $15,672 | -11.36% |
| Chernett Jorey | 10 percent owner | 2618540 10.8091% | $21.84M | 1 | 0 | |
| ABALLI JOHN | President and CEO | 805540 3.3252% | $6.72M | 3 | 5 | +62.1% |
| Black Jeffrey G. | Chief Financial Officer | 323339 1.3347% | $2.7M | 1 | 3 | +121.48% |
| H.I.G. Bio-Exagen, L.P. | 10 percent owner | 1696252 7.002% | $14.15M | 1 | 0 | <0.0001% |
| TULLIS JAMES L L | 10 percent owner | 1515839 6.2573% | $12.64M | 1 | 24 | <0.0001% |
| Johnson Wendy S. | director | 1000 0.0041% | $8,340.00 | 1 | 0 | <0.0001% |
| Increased Positions | 59 | +115.69% | 4M | +43.54% |
| Decreased Positions | 23 | -45.1% | 2M | -24.05% |
| New Positions | 26 | New | 2M | New |
| Sold Out Positions | 8 | Sold Out | 940,262 | Sold Out |
| Total Postitions | 87 | +70.59% | 11M | +19.48% |
| Rtw Investments, Lp | $10,249.00 | 7.38% | 1.7M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $4,432.00 | 3.19% | 733,824 | +52,205 | +7.66% | 2025-09-30 |
| Balyasny Asset Management L.P. | $4,370.00 | 3.15% | 723,428 | +4,646 | +0.65% | 2025-09-30 |
| Invesco Ltd. | $4,078.00 | 2.94% | 675,192 | +675,192 | New | 2025-09-30 |
| Kennedy Capital Management Llc | $3,333.00 | 2.4% | 551,848 | +241,127 | +77.6% | 2025-09-30 |
| Silvercrest Asset Management Group Llc | $3,138.00 | 2.26% | 519,468 | -12,299 | -2.31% | 2025-09-30 |
| Wexford Capital Lp | $2,687.00 | 1.93% | 444,927 | +28,579 | +6.86% | 2025-09-30 |
| Millennium Management Llc | $1,493.00 | 1.08% | 247,173 | +247,173 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $1,437.00 | 1.04% | 237,979 | +174,979 | +277.74% | 2025-09-30 |
| Russell Investments Group, Ltd. | $1,384.00 | 1% | 229,115 | +8,499 | +3.85% | 2025-09-30 |